Alkermes
research collaborations with leading institutes explore further potential clinical utility of principal investigator and institute research collaborations clinic college of medicine kin wong health james welsh the university of cancer center and lan university of medical center soc standard of care preclinical collaboration to study combinations of with multiple immune inhibitors in individualized humanized melanoma models preclinical collaboration to study novel combinations of with soc chemotherapy in mouse lung tumor models preclinical collaboration to study combinations of with novel radiation approaches in mouse models of immune inhibitor resistance preclinical collaboration to study the effects of on the human tumor in multiple solid tumor types in | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
98 of 144
Related slides by other companies
Enochian Biosciences
Investor Presentation
January 2024
expanding preclinical testing in various solid tumors and disease progression stages | Enochian Biosciences
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io